The impetus for developing the NACS was in part to,,,Satisfy Food and Drug Administration requirements that.Drugs used in the clinical arena have a minimal effect on.Neonatal neurobehavior.1 The Food and Drug Administration.Wanted a means of quantifying the neonatal effects.Of new drugs and established medications.Whether the NACS is a suitable method to satisfy these.Requirements has not been confirmed.
การแปล กรุณารอสักครู่..
